BackgroundCheck.run
Search For

Scott W Altmann, 64514 8Th Ave, Tinton Falls, NJ 07712

Known as:
Scott William Altmann Scott M Altmann Scott Tiarnaigh
Related to:
Kazuki Hayashi 23

Scott Altmann Phones & Addresses

514 8Th Ave, Asbury Park, NJ 07712    732-5028933   

42 1St St, Fanwood, NJ 07023    908-8897910    908-8890909   

Kenilworth, NJ   

Philadelphia, PA   

Walpole, MA   

Palo Alto, CA   

Fremont, CA   

Get Report
Control this profile

Mentions for Scott W Altmann

Scott Altmann resumes & CV records

Resumes

Scott Altmann Photo 31

Founder And Chief Strategy Officer

Location:
Allenhurst, NJ
Industry:
Biotechnology
Work:
Merck Research Labs Dec 2010 - Feb 2011
Principal Scientist Hdl Apomics Dec 2010 - Feb 2011
Founder and Chief Strategy Officer Schering-Plough Research Institute Feb 1996 - Dec 2010
Principal Scientist Dnax Research Institute 1992 - 1996
Post-Doctoral Fellow
Education:
University of Pennsylvania 1984 - 1991
Doctorates, Doctor of Philosophy, Molecular Biology Northeastern University 1980 - 1984
Bachelors, Bachelor of Science, Biology
Skills:
Drug Discovery, Bioinformatics, Biotechnology, Molecular Biology, Life Sciences, Protein Expression, Validation, Assay Development, Biomarkers, Drug Development, Biomarker Discovery, Clinical Development, Monoclonal Antibodies, Antibodies, Immunology, Biochemistry, Pharmaceutical Industry, Target Identification, Analytics, Proteomics
Interests:
Music
Landscaping and Blue
Non Scientific Interests Include
Motorcycles
Scott Altmann Photo 32

Illustration / Painter / Imagery

Location:
Greater New York City Area
Industry:
Entertainment

Publications & IP owners

Us Patents

Use Of Azetidinone Compounds

US Patent:
6593078, Jul 15, 2003
Filed:
Apr 12, 2000
Appl. No.:
09/547509
Inventors:
Scott W. Altmann - Fanwood NJ
Duane A. Burnett - Bernardsville NJ
Michael P. Graziano - Scotch Plains NJ
Maureen Laverty - Metuchen NJ
Xiaorui Yao - Edison NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q 100
US Classification:
435 4, 435 6, 435 71, 435 721, 514 23, 51421002
Abstract:
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or cholesteryl esters in biological systems is presented. These compounds can serve as tools for competitive binding assays to discover and characterize other chemical agents useful as cholesterol absorption inhibitors. New compounds of the present invention are also highly efficacious inhibitors of cholesterol absorption.

Use Of Azetidinone Compounds

US Patent:
6632933, Oct 14, 2003
Filed:
Jul 30, 2001
Appl. No.:
09/918397
Inventors:
Scott W. Altmann - Fanwood NJ
Duane A. Burnett - Bernardsville NJ
Michael P. Graziano - Scotch Plains NJ
Maureen Laverty - Metuchen NJ
Xiaorui Yao - Edison NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07H 1526
US Classification:
536 174, 540200, 548405, 549224, 514 23, 51421002
Abstract:
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or cholesteryl esters in biological systems is presented. These compounds can serve as tools for competitive binding assays to discover and characterize other chemical agents useful as cholesterol absorption inhibitors. New compounds of the present invention are also highly efficacious inhibitors of cholesterol absorption.

Use Of Azetidinone Compounds

US Patent:
6933107, Aug 23, 2005
Filed:
May 15, 2003
Appl. No.:
10/438637
Inventors:
Scott W. Altmann - Fanwood NJ, US
Duane A. Burnett - Bernardsville NJ, US
Michael P. Graziano - Scotch Plains NJ, US
Maureen Laverty - Metuchen NJ, US
Xiaorui Yao - Edison NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q001/68
C07K014/47
US Classification:
435 4, 435 71, 435 72, 435 721, 514 23, 51421002
Abstract:
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or cholesteryl esters in biological systems is presented. These compounds can serve as tools for competitive binding assays to discover and characterize other chemical agents useful as cholesterol absorption inhibitors. New compounds of the present invention are also highly efficacious inhibitors of cholesterol absorption.

Npc1L1 (Npc3) And Methods Of Use Thereof

US Patent:
7135556, Nov 14, 2006
Filed:
Dec 16, 2003
Appl. No.:
10/736769
Inventors:
Scott W. Altmann - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Luquan Wang - East Brunswick NJ, US
Michael P. Graziano - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 38/47
C07K 16/24
C07K 16/26
G01N 33/58
G01N 33/531
US Classification:
530395, 530350, 5303913, 435449, 4241921
Abstract:
We claim an isolated polypeptide having ability of binding with cholesterol. Said polypeptide is useful for investigating regulation of intestinal cholesterol absorption and cholesterol levels. Also, we claim a composition comprising said polypeptide bound to cholesterol or ezetimibe and a fusion protein comprising the polypeptide thereof.

Use Of Azetidinone Compounds

US Patent:
7144696, Dec 5, 2006
Filed:
May 6, 2005
Appl. No.:
11/123615
Inventors:
Scott W. Altmann - Fanwood NJ, US
Duane A. Burnett - Bernardsville NJ, US
Michael P. Graziano - Scotch Plains NJ, US
Maureen Laverty - Metuchen NJ, US
Xiaorui Yao - Edison NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q 1/00
G01N 33/53
A01N 43/04
US Classification:
435 4, 435 71, 435 72, 435 721, 514 23, 51421002
Abstract:
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or cholesteryl esters in biological systems is presented. These compounds can serve as tools for competitive binding assays to discover and characterize other chemical agents useful as cholesterol absorption inhibitors. New compounds of the present invention are also highly efficacious inhibitors of cholesterol absorption.

Use Of Azetidinone Compounds

US Patent:
7723020, May 25, 2010
Filed:
Oct 25, 2006
Appl. No.:
11/586303
Inventors:
Scott W. Altmann - Fanwood NJ, US
Duane A. Burnett - Bernardsville NJ, US
Michael P. Graziano - Scotch Plains NJ, US
Maureen Laverty - Old Bridge NJ, US
Xiaorui Yao - Piscataway NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q 1/00
G01N 33/53
G01N 33/567
A01N 43/04
A61K 31/397
US Classification:
435 4, 435 71, 435 72, 435 721, 514 23, 51421002
Abstract:
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or cholesteryl esters in biological systems is presented. These compounds can serve as tools for competitive binding assays to discover and characterize other chemical agents useful as cholesterol absorption inhibitors. New compounds of the present invention are also highly efficacious inhibitors of cholesterol absorption.

Npc1L1 Orthologues

US Patent:
7910698, Mar 22, 2011
Filed:
Feb 22, 2007
Appl. No.:
11/710295
Inventors:
Scott Altmann - Asbury Park NJ, US
Xiaorui Yao - Piscataway NJ, US
Kim Ann O'Neill - Scotch Plains NJ, US
Brian E. Hawes - Hillsborough NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07K 14/00
C12N 11/00
C12P 21/06
C12P 21/04
C12Q 1/00
G01N 33/567
G01N 33/53
G01N 33/00
C12Q 1/16
A01N 37/18
A61K 38/16
A61K 38/00
US Classification:
530350, 435174, 435 691, 435 697, 435 4, 435 721, 435 771, 435 78, 435 793, 435 35, 514 2, 514 8, 514 21
Abstract:
The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e. g. , in screening assays, are also set forth.

Npc1L1 Orthologues

US Patent:
8212016, Jul 3, 2012
Filed:
Feb 14, 2011
Appl. No.:
13/026763
Inventors:
Scott W. Altmann - Asbury Park NJ, US
Xiaorui Yao - Piscataway NJ, US
Kim Anne O'Neill - Scotch Plains NJ, US
Brian E. Hawes - Hillsborough NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07H 21/02
C12P 21/06
C12N 15/00
C12N 5/00
C12N 1/20
C12N 1/00
C12N 5/04
C12N 5/10
US Classification:
536 231, 4353201, 435 691, 435325, 4352523, 43525411, 435419, 4352542
Abstract:
The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e. g. , in screening assays, are also set forth.

Isbn (Books And Publications)

Chemical Water Treatment: Principles And Practice

Author:
Scott Altmann
ISBN #:
0471185639

Possible Relatives

David P Altmann  Dale A Altmann  Edward B Altmann  Elizabeth L Altmann  Eric W Altmann  Erik J Altmann  Frank H Altmann  Scott D Johnson  Scott A Stanard  Scott B Standley 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.